Study guide
10.1 Myasthenia Gravis (Postsynaptic)
Registered Nerve Conduction Studies Technologist R.NCS.T.
Track your progress as you read
Finished sections get a check mark.
1 Exam Overview
1.1 Current Exam Facts 1.2 Eligibility, Documentation, and Application 1.3 Scoring, Recertification, and Test Day
2 Membrane Physiology and Action Potentials
2.1 Resting Membrane Potential and Cell Membrane Physiology 2.2 Action Potential Phases, All-or-None Response, and Refractory Periods 2.3 Saltatory Conduction, Myelin, and Nodes of Ranvier
3 Peripheral Nerve Structure and Cell Bodies
3.1 Fascicles and Nerve Connective Tissues 3.2 Peripheral Nerve Fiber Types 3.3 Motor and Sensory Cell-Body Locations
4 Muscle Physiology, Roots, and Plexuses
4.1 Skeletal Muscle Structure: Myofibrils, Sarcomeres, and Bands 4.2 Excitation-Contraction Coupling 4.3 Spinal Roots, Dorsal and Ventral Roots, and Rami 4.4 Brachial and Lumbosacral Plexus Organization
5 Electronics, Instrumentation, and Stimulation
5.1 Ohm’s Law, AC/DC Circuits, and Resistance 5.2 Amplifiers, Filters, Averaging, and Display Settings 5.3 Stimulators, Polarity, and Stimulation Pitfalls
6 Waveform Parameters, Conduction Velocity, and Pediatric NCS
6.1 Latency, Amplitude, Duration, Area, and Rise Time 6.2 Conduction Velocity Calculation and Normal Values 6.3 Pediatric Nerve Conduction Studies
7 Lesion Patterns and Wallerian Degeneration
7.1 Preganglionic versus Postganglionic Lesions 7.2 Focal Lesions, Conduction Block, Demyelination, and Temporal Dispersion 7.3 Axonal Loss, Wallerian Degeneration, and Nerve-Injury Grades
8 Late Responses and the Blink Reflex
8.1 F Waves: Origin, Technique, and Clinical Use 8.2 H Reflexes: Origin, Technique, and Clinical Use 8.3 A Waves and the Blink Reflex
9 NMJ Physiology and Repetitive Nerve Stimulation
9.1 Neuromuscular Junction Anatomy and Physiology 9.2 Repetitive Nerve Stimulation: Technical Setup 9.3 Post-Activation Facilitation, Exhaustion, and Pseudofacilitation
10 Neuromuscular Junction Disorders
10.1 Myasthenia Gravis (Postsynaptic) 10.2 Lambert-Eaton Myasthenic Syndrome 10.3 Botulism and Presynaptic Toxin Patterns
11 Upper-Extremity Nerve Conduction Protocols
11.1 Median Motor, Sensory, AIN, and Palmar Cutaneous Studies 11.2 Ulnar Motor, Sensory, Dorsal Ulnar Cutaneous, and Medial Antebrachial Studies 11.3 Radial Motor, Posterior Interosseous, and Superficial Radial Studies
12 Upper-Extremity Entrapments and Mononeuropathies
12.1 Median Neuropathy at the Wrist (Carpal Tunnel) 12.2 Ulnar Neuropathy at the Elbow and Guyon’s Canal 12.3 Radial Neuropathy (Saturday Night Palsy) and Related UE Mononeuropathies
13 Lower-Extremity Nerve Conduction Protocols
13.1 Common, Deep, and Superficial Fibular (Peroneal) Studies 13.2 Tibial Motor and Medial/Lateral Plantar Studies 13.3 Sural, Saphenous, and Lateral Femoral Cutaneous Studies
14 Lower-Extremity Neuropathies and Proximal Nerves
14.1 Fibular Neuropathy at the Fibular Head versus L5 Radiculopathy 14.2 Tarsal Tunnel, Tibial Neuropathy, and S1 Localization 14.3 Femoral, Sciatic, and Lateral Femoral Cutaneous Neuropathies
15 Cranial Nerves, Other Nerves, and Plexus Lesions
15.1 Cranial Nerves with Facial, Trigeminal, and Accessory Studies 15.2 Phrenic, Suprascapular, Long Thoracic, and Axillary Nerves 15.3 Plexus Lesions: Erb’s Palsy, Neurogenic TOS, and Parsonage-Turner
16 Root, Motor Neuron, Polyneuropathy, and Muscle Disorders
16.1 Radiculopathy, Root Avulsion, and Sensory Neuronopathy 16.2 Motor Neuron Disease and Multifocal Motor Neuropathy 16.3 Polyneuropathies, Mononeuropathy Multiplex, and Muscle Disorders
17 Temperature, Age, Height, and Martin-Gruber Anastomosis
17.1 Temperature Effects and Warming Methods 17.2 Age and Height Effects on Nerve Conduction 17.3 Martin-Gruber Anastomosis Patterns
18 Anomalous Innervation, Technical Factors, and Safety
18.1 Riche-Cannieu Anastomosis and Accessory Fibular Nerve 18.2 Technical Factors and Troubleshooting Abnormal Studies 18.3 Infection Control, Electrical Safety, HIPAA, and OSHA
10.1 Myasthenia Gravis (Postsynaptic)
Key Takeaways Explain This Topic AI
Myasthenia gravis is postsynaptic: acetylcholine-receptor antibodies are the most common serology; a MuSK subset is often facial and bulbar and may show less limb decrement.
Baseline CMAP amplitude is usually normal; the electrodiagnostic signature is a slow-RNS decrement, not a tiny resting CMAP.
A valid slow train (typically 2–3 Hz) may show a U-shaped decrement that repairs after brief isometric exercise and then deepens during post-activation exhaustion at about 1–3 minutes.
Single-fiber EMG is more sensitive than RNS but is a physician-level needle skill, not a technologist NCS task; edrophonium (Tensilon) is a historical clinical test, not the nerve-conduction diagnosis.
Exam traps include movement artifact mimicking decrement and a cool limb masking a true decrement; ≥10% first-to-fourth drop is common laboratory teaching with lab variation, not an official unpublished AAET cut score.
Last updated: September 2026
10.1 Myasthenia Gravis (Postsynaptic)
Quick Answer: Myasthenia gravis (MG) is the classic postsynaptic neuromuscular-junction disease. Acetylcholine-receptor (AChR) antibodies are the most common serology. The baseline compound muscle action potential (CMAP) is usually normal . Slow repetitive nerve stimulation (RNS) shows a decrement that may repair after brief exercise and then worsen during post-activation exhaustion . Single-fiber EMG (SFEMG) is more sensitive but is a physician-level needle skill , not a technologist NCS task. Edrophonium (Tensilon) is a historical clinical test, not the nerve-conduction diagnosis.
Chapter 9 taught how to immobilize a muscle, run a 2–3 Hz train, and time 10-second versus 1-minute exercise. This section teaches the MG disease pattern those trains are meant to catch. Independent ExamFinch study of outline item V.A.3 Postsynaptic Disorders—Myasthenia Gravis is pattern recognition: where the lesion sits , what the resting CMAP does , and how slow RNS and post-exercise trains behave . This chapter is independent study material for learners preparing for the National Registry Examination for Nerve Conduction Studies . It is not a publication of the American Association of Electrodiagnostic Technologists (AAET) and does not claim official approval, review, partnership, or exact equivalence with the handbook outline.
Mechanism: fewer receptors, thinner safety factor
A motor-nerve spike still opens presynaptic voltage-gated Ca2+ channels and still dumps quantal acetylcholine (ACh) into the cleft. In AChR-MG the attack is on the muscle side: autoimmune antibodies bind nicotinic ACh receptors on junctional folds , accelerate receptor degradation, and damage the postsynaptic membrane. Quantal size (the postsynaptic effect of one vesicle) falls. Quantal content (vesicles per nerve impulse) is relatively preserved compared with Lambert-Eaton myasthenic syndrome (LEMS) . The endplate potential (EPP) therefore sits closer to threshold. Safety factor is reduced. Transmission that was 1:1 becomes 1:sometimes . Fibers that flicker around threshold drop out of the CMAP during a slow train, which is why amplitude and area fall together when the study is real.
Do not relocate MG to the nerve terminal. P/Q-type voltage-gated calcium-channel (VGCC) antibodies and SNARE cleavage are presynaptic stories (sections 10.2 and 10.3). MG is postsynaptic .
Antibodies: AChR versus MuSK
AChR antibodies are the most common serologic group in generalized MG in standard teaching. Many patients also have thymic hyperplasia; a subset has thymoma — that association is clinical, not an NCS finding. Muscle-specific kinase (MuSK) antibodies mark a smaller subset that is typically AChR-negative . MuSK-MG teaching emphasizes facial, bulbar, neck, and respiratory weakness more than a classic limb-predominant picture. Limb slow-RNS decrement may be modest or absent even when the face is clearly involved, which is why a taped nasalis or other cranial/proximal site is not optional decoration.
Antibody / group Typical teaching role Clinical flavor RNS teaching point
AChR (most common) Postsynaptic nicotinic-receptor attack Fatigable ocular , bulbar , and limb weakness Classic slow-RNS decrement in weak muscles; distal hand may be less sensitive
MuSK (subset) Postsynaptic MuSK pathway; usually AChR-negative Facial/bulbar prominent; neck and respiratory risk Less limb decrement in many patients; study the face and weak muscles
Seronegative / other Does not erase the physiology Variable Record clinically involved muscles; serology is not the CMAP
Other antibodies exist in the wider myasthenia literature. For this outline, lock AChR = most common and MuSK = facial/bulbar subset that may spare the hand decrement .
Clinical pattern the technologist should recognize
Fatigable weakness is the bedside signature. Extraocular muscles produce ptosis and diplopia . Bulbar involvement produces dysarthria , dysphagia , and nasal speech that worsen with talking. Limb fatigue appears with repeated effort. Symptoms often worsen later in the day. Pupils are typically spared — a high-yield contrast with botulism . Tendon reflexes are usually preserved — a high-yield contrast with LEMS . Prominent autonomic failure (dry mouth as a dominant complaint, impotence, ileus) is not the MG hallmark.
Ocular MG can live almost entirely in the extraocular muscles. A normal ulnar abductor digiti minimi (ADM) train does not clear those junctions. That is a disease-pattern statement built on the sensitivity teaching from section 9.2, not a new electrode recipe.
Baseline CMAP: usually normal
At rest, enough endplates still clear threshold that a single supramaximal shock yields a normal or near-normal CMAP in typical MG teaching. One impulse barely taxes the remaining safety factor. That is the key amplitude contrast with LEMS and botulism , where resting quantal content is so low that the baseline CMAP is small .
If ADM is 1.5 mV at rest in a warm, well-placed montage, do not call that "classic MG" on amplitude alone. Think presynaptic disease, axonal loss , or technical failure, then use the increment/decrement pattern. If ADM is 8 mV and then decrements at 3 Hz, you are in the MG amplitude neighborhood.
Brief recall of slow RNS — then the MG envelope
Do not rebuild chapter 9. Recall only what the MG tracing needs:
Immobilize (tape, board, isometric). Movement artifact can raise or lower CMAP amplitude and mimic decrement .
Warm the muscle. A cool limb can mask decrement by raising safety factor.
Stimulus supramaximal before the train.
Slow RNS typically 2–3 Hz (sometimes 3–5 Hz ), about 8–10 stimuli .
Common teaching measures percent decrement from the first CMAP to the fourth CMAP .
A decrement of 10 percent or more is a frequently cited laboratory teaching threshold , with lab variation . It is not an official unpublished AAET cut score.
The MG envelope is often U-shaped : decrement usually maximal by about the fourth response, then a slight repair later in the train as transmitter dynamics shift. Read area with amplitude . A peak that falls while duration stretches and area holds is not the same as fiber dropout.
Proximal and facial muscles (nasalis, trapezius, anconeus) are often more sensitive than ADM or abductor pollicis brevis (APB) because clinically involved junctions carry a thinner safety factor. Study a technically clean distal muscle and a weak proximal/facial muscle. In MuSK disease, that facial emphasis is even more important.
Post-exercise: repair, then exhaustion
Chapter 9 defined the clock. MG uses that clock as follows.
Brief isometric exercise (about 10 seconds) is the facilitation / repair window. Immediately afterward, a myasthenic decrement may lessen or disappear . The resting CMAP itself usually does not leap to double or triple its baseline the way a LEMS CMAP can. Repair of decrement is not a 167 percent increment.
Prolonged isometric exercise (about 1 minute) , then slow trains at about 1, 2, and 3 minutes , is the post-activation exhaustion window. A myasthenic decrement may worsen as vesicles and receptor availability are taxed. Exhaustion is delayed; it is not the immediate 10-second tracing.
- Stage Typical MG teaching pattern
- Baseline CMAP Usually normal
- Slow RNS (2–3 Hz) Decrement , often U-shaped; first-to-fourth comparison; area falls with amplitude
- Immediately after ~10 s exercise Decrement may repair ; large CMAP increment is not the MG signature
- After prolonged (~1 min) exercise, ~1–3 min later Exhaustion : decrement may deepen
- SFEMG and Tensilon: know their lane
SFEMG can show increased jitter and blocking and is more sensitive than RNS for a neuromuscular-transmission defect. It is a physician-level needle examination. It is not a technologist NCS skill on this outline. Mention sensitivity; do not write an SFEMG protocol and do not claim to perform it as part of routine nerve conduction studies.
Edrophonium (Tensilon) is a short-acting acetylcholinesterase inhibitor used historically at the bedside to look for brief improvement of ptosis. It is a clinical/historical test. It is not the nerve-conduction diagnosis. It does not replace a valid, warm, immobilized slow-RNS study. Safety (including bradycardia) belongs to the clinician performing that test, not to a CMAP cursor. An ice-pack test at the bedside is likewise clinical, not an NCS result.
Worked MG numbers
ADM is taped, warm, and 8.0 mV at rest. A 3 Hz train of 10 stimuli: first CMAP 8.0 mV , fourth 6.4 mV . Percent decrement = (8.0 − 6.4) / 8.0 × 100 = 20 percent , with a matching area drop and a U-shape. After 10 seconds of isometric fifth-digit abduction, the first CMAP is still about 8.1 mV and the fourth is 7.6 mV (about 6 percent) — repair , not a LEMS jump. After 1 minute of exercise, a 3 Hz train at 2 minutes shows 7.8 mV then 5.5 mV (about 29 percent) — exhaustion . None of these percentages is an official AAET published cutoff; they illustrate the pattern .
If the same 20 percent "decrement" appeared only while the wrist flexed and vanished after retaping, it was movement , not MG. If the muscle was iced "for comfort" and the train was flat, you may have masked a real decrement.
- Exam traps
- Decrement from movement artifact (G1 slide, cathode shift, wrist roll) labeled as MG
- Cool limb masking decrement , then reporting no neuromuscular-junction defect
- Studying only ADM in ocular, bulbar, or MuSK disease
- Calling a large post-exercise CMAP increment MG (think LEMS)
- Treating Tensilon as the NCS gold standard
- Treating SFEMG as a technologist needle task
Inventing an official AAET decrement cut score instead of teaching ≥10% as common laboratory language with variation
The MG pattern in one line: postsynaptic AChR (or MuSK subset), normal resting CMAP, slow-RNS decrement that may repair after brief exercise and worsen in exhaustion, pupils and reflexes usually spared.